137
Views
4
CrossRef citations to date
0
Altmetric
Review

Opportunities for inhaler device selection in elderly patients with asthma or COPD

, &
Pages 53-65 | Published online: 04 Dec 2015

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. GOLD. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf. Accessed May 18, 2015.
  • Melani AS. Management of asthma in the elderly patient. Clin Interv Aging. 2013;8:913–922.
  • Yanez A, Sang-Hoen C, Soriano JB, et al. Asthma in the elderly: what we know and what we have yet to know. World Allergy Organ J. 2014;7(1):8.
  • Papaiwannou A, Zarogoulidis P, Porpodis K, et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis. 2014;6 Suppl 1:S146–S151.
  • Krishnan V, Diette GB, Rand CS, et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med. 2006,174(6):633–638.
  • Luskin AT, Chipps BE, Rasouliyan L, Miller DP, Haselkorn T, Dorenbaum A. Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol Pract. 2014;2(5):544–552.
  • Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy and Immunology. Chest. 2005;127(1):335–371.
  • Brocklebank D, Ram F, Wright J, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5(26):1–149.
  • Slejko JF, Ghushchyan VH, Sucher B, et al. Asthma control in the United States, 2008–2010: indicators of poor asthma control. J Allergy Clin Immunol. 2014;133(6):1579–1587.
  • Bryant J, McDonald VM, Boyes A, Sanson-Fisher R, Paul C, and Melville J. Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res. 2013;14:109.
  • Global Initiative for Asthma [homepage on the Internet]. Global strategy for asthma management and prevention [updated 2009]. Available from: http://www.ginasthma.org/guidelines-gina-report-global-strategy-forasthma.html. Accessed May 20, 2015.
  • Hanania NA, King MJ, Braman SS, et al. Asthma in the elderly: Current understanding and future research needs – a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011;128(3 Suppl):S4–S24.
  • Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J. 2002;78(915):37–39.
  • Allen SC, Jain M, Ragab S, Malik N. Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing. 2003;32(3):299–302.
  • Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156(9):984–988.
  • Armitage JM, Williams SJ. Inhaler technique in the elderly. Age Ageing.1988;17(4):275–278.
  • Khassawneh BY, Al-Ali MK, Alzoubi KH, et al. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers. Respir Care. 2008;53(3):324–328.
  • Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988–2010. J Gerontol A Biol Sci Med Sci. 2015;70(8):989–995.
  • Nobili A, Garatinni S, Mannucci PM. Multiple diseases and polypharmacy in the elderly; challenges for the internist of the third millennium. J Comorbidity. 2011;1:28–44.
  • Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371–384.
  • Bateman ED. Treatment adherence in asthmatic patients: the last frontier? J Allergy Clin Immunol. 2014;134(6):1269–1270.
  • Roy A, Battle K, Lurslurchachai L, Halm EA, Wisnivesky JP. Inhaler device, administration technique, and adherence to inhaled corticosteroids in patients with asthma. Prim Care Respir J. 2011;20(2):148–154.
  • Administration on Aging. A Profile of Older Americans: 2012. Administration for Community Living. US Department of Health and Human Services. Available from: http://www.aoa.gov/Aging_Statistics/Profile/2012/docs/2012profile.pdf. Assessed May 23, 2015.
  • Employee Benefit Research Institute. Health Insurance and the Elderly. Available from:http://www.ebri.org/pdf/publications/facts/0813fact.pdf. Accessed May 23, 2015.
  • Q1Medicare.com 2015 Drug Finder [homepage on the Internet]. Search for your prescription drug across all Medicare Part of Medicare Advantage Plans. ADVAIR DISKUS MIS 500/50. Available from: http://www.q1medicare.com/PartD-SearchPDPMedicarePartDDrugFinder.php?stateReg=14OH&plans=Humana&plans2=AARP&sort=&ded=&gap=&prem=&ndc=00173069700&drug=ADVAIR%20DISKU%20MIS%20500/50). Accessed May 24, 2015.
  • Joyce GF, Zissimopoulos J, Goldman DP. Digesting the doughnut hole. J Health Econ. 2013;32(6):1345–1355.
  • Q1Medicare.com 2015 Drug Finder [homepage on the Internet]. Search for your prescription drug across all Medicare Part of Medicare Advantage Plans. Available from: http://www.q1medicare.com/PartD-SearchPDPMedicarePartDDrugFinder.php. Accessed May 24, 2015.
  • US Department of Health and Human Services [homepage on the Internet]. The Affordable Care Act and Older Americans. US Department of Health and Human Services. Available from: http://www.hhs.gov/healthcare/facts/factsheets/2015/03/affordable-care-act-older-americans.html#discounts. Accessed May 25, 2015.
  • Fink JB. Metered-dose inhalers, dry powder inhalers, and transitions. Respir Care. 2000;45(6):623–635.
  • Lavorini F, Fontana GA, Usmani OS. New inhaler devices – the good, the bad and the ugly. Respiration. 2014;88(1):3–15.
  • Broeders ME, Sanchisb J, Levy ML, Cromptond GK, Dekhuijzena PN; ADMIT Working Group. The ADMIT series – issues in inhalation therapy. 2. Improving technique and clinical effectiveness. Prim Care Respir J. 2009;18(2):76–82.
  • McFadden ER Jr. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J Allergy Clin Immunol. 1995;96(2):278–283.
  • Haughney J, Price D, Barnes NC, Virchow JC, Roche N, Chrystyn H. Choosing inhaler devices for people with asthma. Current knowledge and outstanding research needs. Respir Med. 2010;104(9):1237–1245.
  • Rau JL. The inhalation of drugs: advantages and problems. Respir Care. 2005;50(3):3673–3682.
  • Sadowski CA, Cor K, Cave A, and Banh HL. Administration Technique and acceptance of inhaler devices in patients with Asthma and COPD. Ann Pharmacother. 2015;49(6):639–648.
  • Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. European Respiratory Society; International Society for Aerosols in Medicine. Eur Respir J. 2011;37(6):1308–1331.
  • Anderson P. Use of Respimat Soft Mist inhaler in COPD patients. Int J Chron Obstruct Pulmon Dis. 2006;1(3):251–259.
  • Hodder R, Reese PR, Slaton T. Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler. Int J Chron Obstruct Pulmon Dis. 2009;4:225–232.
  • Brand P, Hederer B, Austen G, Dewberry H, Meyer T. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique. Int J Chron Obstruct Pulmon Dis. 2008;3(4):763–770.
  • Schürmann W, Schmidtmann S, Moroni P, Massey D, Qidan M. Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction. Treat Respir Med. 2005;4(1):53–61.
  • Freytag F, Rau-Berger H, Glaab T, et al. Respimat® Soft Mist™ Inhaler preferred to Diskus by patients with COPD and/or asthma. Am J Respir Crit Care Med. 2007;175:A639.
  • Islam N, Gladki E. Dry powder inhalers (DPIs) – a review of device reliability and innovation. Int J Pharm. 2008;360(1–2):1–11.
  • Newman SP. Drug delivery to the lungs from dry powder inhalers. Curr Opin Pulm Med. 2003;9 Suppl 1:S17–S20.
  • Demoly P, Hagedoorn P, de Boer AH, Frijlink HW. The clinical relevance of dry powder inhaler performance for drug delivery. Respir Med. 2014;108(8):1195–1203.
  • Janssens W, VandenBrande P, Hardeman E, et al. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J. 2008;31(1):78–83.
  • Yang MY, Chan JG, Chan HK. Pulmonary drug delivery by powder aerosols. J Control Release. 2014;193:228–240.
  • Jarvis, S, Ind PW, Shiner RJ. Inhaled therapy in elderly COPD patients; time for re-evaluation? Age Ageing. 2007;36(2):213–218.
  • Chrystyn H. Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates. Respir Med. 2003;97(2):181–187.
  • Hess DR. Metered-dose inhalers and dry powder inhalers in aerosol therapy. Respir Care. 2005;50(10):1376–1383.
  • Atkins PJ. Dry powder inhalers: an overview. Respir Care. 2005;50(10):1304–1312.
  • Meakin BJ, Cainey J, Woodcock PM. Effect of exposure to humidity on terbutaline delivery from Turbuhaler dry powder inhalation devices. Eur Respir J. 1993;6(5):760–761.
  • Santus P, Picciolo S, Proietto A, et al. Doctor-patient relationship: a resource to improve respiratory diseases management. Eur J Intern Med. 2012;23(5):442–446.
  • Chorão P, Pereira AM, Fonseca JA. Inhaler devices in asthma and COPD – an assessment of inhaler technique and patient preferences. Respir Med. 2014;108(7):968–975.
  • Svedsater H, Dale P, Garrill K, Walker R, Woepse MW. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD. BMC Pulm Med. 2013;13:72.
  • Hess DR. Nebulizers: principles and performance. Respir Care. 2000;45(6):609–622.
  • Rau JL. Practical problems with aerosol therapy in COPD. Respir Care. 2006;51(2):158–172.
  • Filuk R. Delivery system selection: clinical considerations. Am Health Drug Benefits. 2008;1(Suppl 8):13–17.
  • Geller DE. Comparing clinical features of nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care. 2005;50(10):1313–1321.
  • Balzano G, Battiloro R, Biraghi M. Effectiveness and acceptability of domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. J Aerosol Med. 2000;13(1):25–33.
  • Barta SK, Crawford A, Roberts CM. Survey of patients’ views of domiciliary nebuliser treatment for chronic lung disease. Respir Med. 2002;96(60):375–381.
  • Nikander K. Adaptive aerosol delivery: the principles. Eur Respir Rev. 1999;7:385–389.
  • Cobben NA, Drent M, Jonkers M, Wouters EF, Vaneechoutte M, Stobberingh EE. Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers. J Hosp Infect. 1996;33(1):63–70.
  • Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011;377(9770):1032–1045.
  • Pulmicort (budesonide) [package insert]. Wilmington, DE: AstraZeneca LP; 2009.
  • Kirsch IS, Jungebut A, Jenkins L, Kolstad A. National Center for Education Statistics. Adult literacy in America. A first look at the findings of the National Adult Literacy Survey. 3rd ed. US Department of Education, Office of Educational Research and Improvement; 2002.
  • Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50(10):1360–1374.
  • Press VG, Arora VM, Shah LM, et al. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. J Gen Intern Med. 2012;27(10):1317–1325.
  • Paasche-Orlow MK, Riebert KA, Bilderback A, et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med. 2005;172(8):980–986.
  • Kiser K, Jonas D, Warner Z, Scanlon K, Shilliday BB, DeWalt DA. A randomized controlled trial of a literacy-sensitive self-management intervention for chronic obstructive pulmonary disease patients. J Gen Intern Med. 2011;27(2):190–195.
  • Baker DW, Gazmararian JA, Sudano J, Patterson M. The association between age and health literacy among elderly persons. J Gerontol B Psychol Sci Soc Sci. 2000;55(6):S368–S374.
  • Williams MV, Baker DW, Honig EG, Lee TM, Nowlan A. Inadequate literacy is a barrier to asthma knowledge and self-care. Chest. 1998;114(4):1008–1015.
  • Press VG, Arora VM, Shah LM, et al. Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. J Gen Intern Med. 2011;26(6):635–642.
  • Crane MA, Jenkins CR, Goeman DP, Douglass JA. Inhaler device technique can be improved in older adults through tailored education: findings from a randomised controlled trial. NPJ Prim Care Respir Med. 2014;24:14034.
  • Bosnic-Anticevich SZ, Sinha H, So S, Reddel HK. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma. 2010;47(3):251–256.
  • Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care. 2005;50(5):617–623.
  • Self TH, Arnold LB, Czosnowski LM, Swanson JM, Swanson H. Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma. 2007;44(8):593–598.
  • Erickson SR, Landino HM, Zarowitz BJ, Kirking DM. Pharmacists’ understanding of patient education on metered-dose inhaler technique. Ann Pharmacother. 2000;34(11):1249–1256.
  • Johnson DH, Robart P. Inhaler technique of outpatients in the home. Respir Care. 2000;45(10):1182–1187.
  • Newman SP. Inhaler treatment options in COPD. Eur Respir Rev. 2005;14(96):102–108.
  • Foster JM, Usherwood T, Smith L, et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. J Allergy Clin Immunol. 2014;134(6):1260–1268.
  • Chan AH, Harrison J, Black PN, Mitchell EA, Foster JM. Using electronic monitoring devices to measure inhaler adherence: a practical guide for clinicians. J Allergy Clin Immunol Pract. 2015;3(3):335–349.
  • Bender B, Wamboldt FS, O’Connor SL, et al. Measurement of children’s asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol. 2000;85(5):416–421.
  • Patel M, Perrin K, Pritchard A, et al. Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology. 2013;18(3):546–552.
  • Williams LK, Joseph CL, Peterson EL, et al. Patients with asthma who do notfill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol. 2007;120(5):1153–1159.
  • Chan AH, Reddel HK, Apter A, Eakin M, Riekert K, Foster JM. Adherence monitoring and e-health: how clinicians and researchers can use technology to promote inhaler adherence for asthma. J Allergy Clin Immunol Pract. 2013;1(5):446–454.
  • Rand CS, Sevick MA. Ethics in adherence promotion and monitoring. Control Clin Trials. 2000;21(5 Suppl):S241–S247.
  • Nikander K, Turpeinen M, Pelkonen AS, Bengtsson T, Selroos O, Haahtela T. True adherence with the Turbuhaler in young children with asthma. Arch Dis Child. 2011;96(2):168–173.
  • Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19(5):696–704.
  • McNamara PS, McCormack P, McDonald AJ, Heaf L, Southern KW. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cysticfibrosis. J Cyst Fibros. 2009;8(4):258–263.
  • Black P, Garratt E, Noonan L, Arandjus C, Salmon B, Sutherland G. An inhaler with ringtones improves compliance with inhaled steroids in childhood asthma. Am J Respir Crit Care Med. 2008;117:A615.
  • Bender BG. Advancing the science of adherence measurement: implications for the clinician. J Allergy Clin Immunol Pract. 2013;1(1):92–93.
  • Weinstein AG. Asthma adherence management for the clinician. J Allergy Clin Immunol Pract. 2013;1(2):123–128.
  • National Asthma Education and Prevention Program. Expert Panel Report-3: Guidelines for the Diagnosis and Management of Asthma. NIH Publication No 08-4051. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2007.
  • Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–577.
  • Vanderman AJ, Moss JM, Bailey JC, Melnyk SD, Brown JN. Inhaler misuse in an older adult population. Consult Pharm. 2015;30(2):92–100.